The proteasome is a major cellular proteinase. Its activity is modulated by cellular oxidants. Hepatitis C core protein and ethanol exposure both cause enhanced oxidant generation. The aim was to investigate whether core protein, by its ability to generate oxidants, alters proteasome activity and whether these alterations are further affected by ethanol exposure. Methods: These interactions were examined in Huh-7 cell lines that expressed inducible HCV core protein and/or constitutive cytochrome P450 2E1 (CYP2E1) and as purified components in a cell-free system. Chymotrypsin-like proteasome activity was measured fluorometrically. Results: Proteasome activity in core-positive 191-20 cells was 20% higher than that in core-negative cells and was enhanced 3-fold in CYP2E1-expressing L14 cells. Exposure of core-positive cells to glutathione ethyl ester, catalase, or the CYP2E1 inhibitor diallyl sulfide partially reversed the elevation of proteasome activity in core-positive cells, whereas ethanol exposure suppressed proteasome activity. The results indicate that proteasome activity was up-regulated by low levels of core-induced oxidative stress but downregulated by high levels of ethanol-elicited stress. These findings were partially mimicked in a cell-free system. Addition of core protein enhanced the peptidase activity of purified 20S proteasome containing the proteasome activator PA28 and was further potentiated by addition of liver mitochondrial and/or microsome fractions. However, proteasome activation was significantly attenuated when fractions were obtained from ethanol-fed animals. Conclusions: HCV core protein interacts with PA28, mitochondrial, and endoplasmic reticulum proteins to cause low levels of oxidant stress and proteasome activation, which is dampened during ethanol metabolism when oxidant generation is higher.
T he proteasome is the major cellular protein-degrading enzyme that degrades 80% of intracellular proteins. The enzyme is crucial for cell survival because it plays a pivotal role in destroying not only normal but also damaged proteins. By degrading short-lived signal transduction factors, the proteasome regulates signal transduction events and the inflammatory response. 1, 2 In the immune response, the proteasome cleaves antigenic proteins to generate peptides for major histocompatibility complex (MHC) class I-restricted antigen presentation. 3 Proteasome function is regulated by the levels of intracellular oxidants. In liver cells, the proteasome is continuously exposed to oxidants because of mitochondrial electron transport as well as high expression levels of cytochrome P4502E1 (CYP2E1). Multiple agents, including viral proteins and ethanol, enhance oxidant generation in the liver.
Hepatitis C virus (HCV) core protein plays an important role in HCV infection pathogenesis. The viral protein is known to induce oxidative stress by its ability to associate with the outer membrane of the mitochondrion. This interaction increases Ca 2ϩ entry, mitochondrial superoxide production, and subsequently elevates generation of reactive oxygen species (ROS) by mitochondrial electron transport complex I. This results in a decreased mitochondrial glutathione (GSH) and in mitochondrial depolarization, which can be augmented by simultaneous endoplasmic reticulum (ER) oxidative stress. 4, 5 The ability of core protein to increase oxidant production has been reported in isolated mitochondria, in cells expressing core protein, in full-length HCV replicon, and in liver mitochondria derived from HCV transgenic mice. 5, 6 These effects of core protein are enhanced in CYP2E1-expressing cells and are further potentiated by alcohol exposure. 4 -7 Because core protein induces oxidant formation and because the proteasome is sensitive to their levels in cells, 8 -10 we postulated that core protein up-regulates proteasome activity. Further induction of oxidative stress by ethanol exposure may revise the effects of core protein on proteasome because ethanol metabolism suppresses proteasome activity. 11, 12 Suppression of proteasome activity may enhance disease progression in HCV-infected, alcohol-consuming patients because it is known that ethanol consumption exacerbates the clinical course of HCV infection in these individuals. 13, 14 To date, specific interactions between proteasome and HCV core protein and the effects of ethanol on these interactions have not been investigated. Hence, we sought to determine specific interactions between HCV core protein and proteasome activity in vitro and in cultured hepatoma cells that have inducible expression of HCV core protein and in cells with and without constitutive expression of CYP2E1.
Materials and Methods

Reagents and Media
High-glucose Dulbecco's modified Eagle medium (DMEM), F12, blasticidin S, and fetal bovine serum (FBS) were purchased from Invitrogen (Carlsbad, CA). G418 and antibody to PA28␣ were from Calbiochem (La Jolla, CA). MeO-Suc-Phe-Leu-Phe-AFC (FLF-AFC) was from MP Biomedicals (Aurora, OH). Other reagents, all of analytical grade quality, were from Sigma Chemical Co (St Louis, MO). PA28 was a gift from Dr George De-Martino, University of Texas Southwestern Medical Center, Dallas, TX.
Cell Lines
Huh7 cells, which express core protein under a tetracycline-repressible promoter, either in CYP2E1-nonexpressing or in CYP2E1-expressing (L-14) cell lines were used in this study. Both cell lines expressed core protein in the absence of tetracycline after 4 days of tetracycline withdrawal and exhibited no core expression in its presence at 2 g/mL ( Figure 1A ). Both core protein and CYP2E1 were detected by Western blot using monoclonal anti-HCV core (Affinity BioReagents, Golden, CO) or anti-CYP2E1 (Calbiochem, La Jolla, CA), respectively. Culture conditions were as described. 7
Cell Treatments
Hepatoma cells were plated onto 96-well black plates with clear bottoms at a density of 5 ϫ 10 3 cells/ well and were incubated in a 1:1 mixture of DMEM/F12, media supplemented with 5% FBS, penicillin-streptomycin, and selective antibiotics (200 g G418/mL for the core protein and 4 g blasticidin S/mL for the CYP2E1 expression). After overnight attachment, cells were treated as described in the text and Figure legends.
Proteasome Purification
20S proteasome was purified from rat livers according to the procedure described. 15 The purification steps included a high-speed (105,000g) centrifugation for 60 minutes followed by a 16-hour centrifugation of the cytosol at 52,000g, DEAE-Sepharose chromatography of the resuspended proteasome pellet, and hydrophobic interaction chromatography on a phenyl-sepharose column. In addition to the above-described purification, the residual enzyme remaining in high-speed supernatant fraction (which was enriched with PA28) was purified as described. 16 
HCV Core Protein Purification
Cloning, expression, and purification of HCV core protein were performed as described by Kunkel et al. 17, 18 Briefly, HCV core residues 1 to 179 (HCVC 179) derived from the AG94 isolate of genotype 1a sequence was amplified by polymerase chain reaction (PCR) and cloned into a pET30a expression vector (Novagen, Gillstown, NJ). Core protein was expressed by transforming Escherichia coli BL21 (DE3) cells with the expression vector. Expression was induced by addition of 1 mmol/L isopropyl-␤-D thiogalactopyranoside. The cells were solubilized by sonication. Lysates were then diluted with 8 mol/L urea and incubated overnight at 4°C with 50 mmol/L dithiothreitol. The supernatant was applied to a cationexchange column (Poros 20 CM) preequilibrated with 0.25 mol/L HEPES, pH 7.0, 8 mol/L urea, and 1.5 mol/L NaCl. Each fraction was separated by SDS-PAGE, and the gels were stained with coomassie blue to identify HCVC 179, which was found in a single peak eluting around 650 mmol/L NaCl. These fractions were subsequently subjected to reverse-phase, high-pressure liquid chromatography (YMC-ODS column; reverse-phase, 150 ϫ 4.6 mm) and eluted with a linear gradient of 20 mmol/L sodiumphosphate-methanol, pH 3.0. Fractions were analyzed as describe above. Eluted fractions containing core protein were pooled and dialyzed overnight at 4°C against refolding buffer (20 mmol/L Tris [pH 7.0], 100 mmol/L NaCl). Proteinase inhibitors were added to the dialyzed sample (50 mol/L leupeptin, 1 mol/L pepstatin A, and 0.5 mmol/L phenylmethylsulfonyl fluoride). The homogeneity of purified core protein was determined by SDS-PAGE and estimated to 98%. Its identity was confirmed by immunoblot using a mouse monoclonal antibody to HCV core protein (Affinity BioReagents).
Mitochondrial Isolation
This was performed according to the procedure of Korenaga et al. 6 The mitochondrial fractions were prepared from livers of C57Bl/6 mice fed the Lieber DeCarli control or ethanol diet for 3 weeks. Briefly, liver tissue was rinsed with ice-cold phosphate-buffered saline and lysed by 20 strokes in a Dounce homogenizer, in 40 mmol/L Tris-HCl, 1 mmol/L EDTA, 150 mmol/L NaCl, (pH 7.4). Homogenates were subjected to low-speed centrifugation, and mitochondrial pellets were obtained by centrifugation at 10,000g for 10 minutes and then were resuspended in 200 mmol/L mannitol, 70 mmol/L EDTA, 10 mmol/L HEPES (pH 7.5). Alternatively, mito-chondria were prepared as described. 19 Contamination of mitochondria with less than 5% of cytosol was detected. The latter was determined by the activity of lactate dehydrogenase in the mitochondrial preparation compared with that in cytosol.
Microsome Isolation
Microsomes were isolated from livers of control and ethanol-fed mice following the fractionation procedure previously published. 19 
Proteasome Activity
Proteasome chymotrypsin-like activity was detected in situ (intact cells) by measuring hydrolysis of the membrane-permeable substrate, methoxy-succinyl-pheleu-phe-7-amido-4-trifluoromethyl coumarin (MeO-Suc-FLF-AFC). 20 To compare and combine the results of several experiments, for which we use different cell passages, proteasome activity expressed as nmol AFC/g DNA in treated samples was divided by proteasome activity in nmol AFC/g DNA in control sample, and this ratio was multiplied by 100%. In vitro assay of chymotrypsin-like activity purified proteasome was performed using the fluorogenic substrate Suc-LLVY-AMC. Briefly, the latter reaction was run in black 96-well plates, at 200 L/well, containing 0.1 mol/L Tris-HCl (pH 7.5) and 13 mol/L Suc-LLVY-AMC substrate. After 15-to 60minute incubation at 37°C, the reaction product, AMC, was detected fluorometrically on a plate reader (Victor 3; Perkin Elmer, Shelton, CT), (excitation, 355 nm; emission, 460 nm). Enzyme specific activity is expressed as nmol AMC/mg protein.
In Vitro Incubations
Purified 20S proteasome (50 g protein/mL) in 0.1 mmol/L Tris-HCl (pH 7.5) was incubated for 10 minutes with increasing quantities of core/mitochondrial mixture. The ratio of core protein to mitochondrial protein in the incubation mixture was always maintained at 1:100,000. Thus, the ratio of core protein to mitochondrial proteins used for these in vitro experiments was comparable with those reported in HCV core proteinexpressing mice. 6 We tested the 20S proteasome activity using 100, 200, or 300 pg core protein using a corresponding amount of mitochondrial protein (ie, 10, 20, and 30 g mitochondrial protein, respectively) in the incubation mixture. The same mass quantities of microsomal proteins were also used. After incubation, the mixtures were assayed for proteasome chymotrypsin-like activity.
Results
Differential Proteasome Activity in Core ؉ (tet ؊ ) and Core ؊ (tet ؉ ) Cells
Proteasome activity was significantly higher in both CYP2E1-negative 191-20 cells and CYP2E1-positive L-14 cells that expressed core protein in the absence of tetracycline as compared with the same cells in the presence of tetracycline. Proteasome chymotrypsin-like activity was 20% higher in core-positive 191-20 cells compared with core-negative 191-20 cells. This activity was 60% higher in the constitutively expressing CYP2E1 core-positive L-14 cells compared with the same cells that do not express core protein ( Figure 1B ). These results clearly indicated an association between HCV core expression and proteasome activity. Tetracycline by itself had no effect on proteasome activity. This was confirmed using the parental core nonexpressing Huh7 cells that were similarly treated with tetracycline ( Figure 1B ).
Because expression of HCV core protein has been shown to generate intracellular oxidants, 7 we tested the effect of various antioxidants on in situ proteasome activity in both 191-20 and L-14 cells. The addition of glutathione ethyl ester (GSH-EE), N-acetyl cysteine, uric acid, diallyl sulfide (DAS), or catalase to the extracellular medium of core-protein cells caused a decrease in proteasome activity that approached the activity level in the core-negative cells ( Figure 1C and D).
Differential Effects of Ethanol Treatment in 191-20 and L-14 Cells
In core-negative and core-positive 191-20 cells, treatment with 50 mmol/L ethanol for 72 hours did not affect proteasome activity (data not shown). However, exposure of CYP2E1-positive L-14 cells to ethanol suppressed proteasome activity by 33% in the presence of core protein (Figure 2A ). Suppression of proteasome activity by ethanol in core-positive cells was blocked by simultaneous exposure to DAS, catalase, or GSH-EE (Figure 2B ).
Biphasic Response of 20S Proteasome to T-butyl Hydroperoxide
To provide an explanation for the observed differential regulation of proteasome activity by core protein, we tested whether the proteasome activity is affected by various doses of the oxidant t-butyl hydroperoxide (t-BOOH). Core-positive, CYP2E1-negative 191-20 cells were treated with increasing concentrations of t-BOOH (10 mol/L to 100 mol/L) for 5 hours, and in situ proteasome activity was measured. Ten mmol/L t-BOOH increased proteasome activity in these cells by 75%, 30 mol/L t-BOOH had no significant effect, and 50 and 100 mol/L t-BOOH completely abolished enzyme activity ( Figure 3 ). We had previously reported a similar biphasic regulation of proteasome in HepG2 cells exposed to the peroxynitrite donor SIN-1, which elevated protea-some activity at low doses and decreased its in situ activity at high doses. 21
In Vitro Activation of Proteasome With Core Protein
To determine whether core protein directly affects proteasome activity in vitro (in the absence of oxidants), we incubated purified 20S proteasome with core protein, as detailed in the Materials and Methods section. The purity of core protein was confirmed (shown in Figure 4A ). However, we utilized 2 different proteasome preparations. One preparation (Pr. 1) contained both 20S proteasome as well as the proteasome activator PA28, as revealed by Western blot analysis ( Figure 4B ). The other preparation (Pr. 2) had undetectable levels of PA28 (Figure 4B) . We observed that the core protein caused a dose-dependent activation of the proteasome only with Pr. 1 preparation and not with Pr. 2 ( Figure 4C ). Such activation was rather specific for core protein because the addition of the same mass of bovine serum albumin or recombinant NS3 protein (Virogen, Inc, Watertown, MA) failed to activate Pr. 1 preparation ( Figure 4C ). The effect of HCV core protein on proteasome preparation was similar to the effect of commercially available HCV core protein (Virogen, Inc) on commercially available 20S proteasome obtained from Boston Biochem ( Figure 4C ). Thus, Pr. 1 preparation was used in all subsequent in vitro incubations.
Effects of Mitochondria and Microsomes on Proteasome Activation by Core Protein
It has been reported that in vivo, HCV core protein associates with the mitochondrial membrane. 4, 5 Therefore, we examined the effects of isolated mitochondria on the 20S proteasome activity modulation by HCV core on the premise that the core protein might function in association with other mitochondrial components. Pr. 1 was incubated with core protein as well as mitochondrial preparations obtained from livers of control or ethanol-fed C57Bl/6 mice. Inclusion of 30 g mitochondrial protein in the incubation mixture (containing 300 pg core) enhanced the activation of proteasome by core protein up to 6.3-fold ( Figure 5A) . In contrast, a 3.2-fold increase in proteasome activation was observed when mitochondria fractions from ethanol-fed mice were used. This indicates a blunted response with mitochondria from ethanol-fed mice ( Figure 5A ). No differences were observed between freshly isolated and frozen mitochondria on core protein-induced proteasome activation. Furthermore, only mitochondria protein used at a 10-g level significantly enhanced the activating effect of recombinant PA28␣, which, by itself, increased proteasome activity by 1.8-fold ( Figure 5B ).
In cells, core protein is associated not only with mitochondria but also with the ER membrane. To determine the effects of ER preparations (ie, microsomes) on coremediated proteasome activation, we conducted similar experiments as with mitochondrial fractions. A 2.3-fold increase in proteasome activity was observed when microsomes from control mice were incubated in the presence of core protein and Pr. 1 proteosome preparation ( Figure 5A ). Microsomes combined with mitochondria caused a 7.4-fold elevation of proteasome activity. Proteasome activation was again attenuated when microsomes from ethanol-fed mice were used with core protein (1.5-fold stimulation). Moreover, there was no further elevation of proteasome activity when microsomes and mitochondria from ethanol-fed mice were combined with core protein ( Figure 5A ). Neither mitochondria nor microsomes by themselves possessed significant proteasome activity (not shown).
Discussion
HCV core protein is degraded by the ubiquitinproteasome pathway, and E6AP has been identified as the specific ubiquitin ligase that marks the protein for deg-radation. 22, 23 Here, we demonstrated that core protein also regulates proteasome activity, which potentially would influence protein catabolism in HCV-infected hepatocytes. Furthermore, this study identifies a dual mechanism of core-mediated proteasome activation via core protein-induced oxidant generation, as was revealed from our cell culture experiments and evidence of cross talk between core protein and PA28-20S complex supported by the cell-free studies.
As already demonstrated by others, 6, 7 191-20 and L-14 cells and core-expressing or nonexpressing mice had differential levels of ROS production/GSH content in mitochondria. Furthermore, Otani et al 7 showed that the ratio between pro-and antioxidative factors (ROS and GSH, respectively) is lowest in core-positive 191-20 cells, with a moderate increase in core-positive L-14 cells, followed by an increase in ethanol and/or t-BOOH-treated core-positive L-14 cells. Thus, in core-positive/CYP2E1negative cells, core protein caused predominant generation of oxidants in mitochondria, whereas, in CYP2E1expressing cells, oxidant generation was initiated by core protein both at the mitochondrial and the ER levels and was potentiated by ethanol treatment.
Here, we utilized the same cell lines, which were exposed (or not) to ethanol, to create varying gradations of oxidant stress. We presumed that the differential levels of oxidant stress differentially regulated the proteasome activity. To mimic this situation, we exposed core-positive 191-20 cells to various doses of the oxidant t-BOOH, which, at low doses, increased proteasome function, and at high doses suppressed proteasome activity. This findings was not limited to t-BOOH, and similar results were reported using various concentrations of hydrogen peroxide as well as the peroxynitrite donor SIN1 in HepG2 cells. 21, 24 Here, we observed enhanced proteasome activity in both core-positive 191-20 and L-14 cells, with a much higher magnitude of proteasome activation in CYP2E1expressing L-14 cells. These results, taken together with previous reports of low to moderate ROS generation/ GSH depletion in core-positive 191-20 and L-14 cells, 7 indicated that these levels of oxidative stress activate proteasome. This conjecture was confirmed by data that showed that treatment with GSH analogs/precursors reversed core-induced proteasome activation in both cell lines. In addition, inclusion of antioxidants (uric acid or catalase) or the CYP2E1 inhibitor DAS lowered proteasome activity in CYP2E1-positive/core-positive L-14 cells to approach the same levels in core-negative cells. However, when L-14 cells were exposed to ethanol (portending a much higher level of oxidant generation), proteasome activity was suppressed. Indeed, a reciprocal relationship between CYP2E1 expression and proteasome activity has been previously reported, 10, 25, 26 and we have also shown a decline in proteasome function by ethanol exposure. 12, 27 The mechanism of this decline in proteasome activity can The effects of mitochondria and microsomes on coreactivated 20S proteasome activity. Mitochondrial and microsome fractions were obtained from livers of control and ethanol-fed mice. 20S proteasome was incubated with 300 pg core protein and an equal mixture of mitochondrial and microsomal proteins (see Materials and Methods section). Proteasome activity was then assayed. Data from 3 experiments are expressed as percent of 20S proteasome activity with core protein alone. Bar columns with different letters are significantly different from each other, and columns with the same letters are not. By themselves, mitochondria and microsomes possess little-to-no proteasome activity (not shown). (B) Effects of mitochondria ϩ core on 20S proteasome after addition of recombinant PA28␣. 20S proteasome (Pr.1) was exposed to PA28 in the presence or absence of core protein and of mitochondria isolated from livers of control (MitoC) or ethanol-fed (MitoE) mice (100 pg core/10 g mitochondria). Data from 3 experiments are expressed as percent of 20S proteasome activity (without additions). Bar columns with different letters are significantly different from each other, and columns with the same letters are not. be attributed, in part, to the inability of PA28 to activate the 20S enzyme when proteasome is heavily oxidatively modified, although low amounts of oxidants facilitate the 20S-PA28 interactions. 21 However, even in the absence of oxidative stress, core protein was able to activate 20S proteasome, which formed the complex with PA28␣ and ␥. This means that, in addition to indirect core-mediated regulation of proteasome activity via oxidant stress, the possibility of direct core-proteasome interactions cannot be excluded. To clarify whether core protein also affects proteasome function via direct protein-proteasome interactions, we used a cell-free system, in which proteasome is exposed to core protein in the absence of oxidative stress. We observed a link between activating effects of core protein only on 20S proteasome copurified with PA28 subunits, indicating that core protein affected 20S proteasome activity by facilitating its interaction with assembled PA28 (␣, ␤, and ␥ subunits). In fact, PA28␣, and to a lesser extent ␤, are known as classical activators of 20S proteasome chymotrypsin-like activity in the cytosol, and ␥ subunit regulates proteasome trypsin-like activity, mainly, in the nucleus. 28, 29 In our study, PA28-20S proteasome complex responded to core protein by increased chymotrypsin-like activity, whereas, as reported earlier, core protein forms a complex with PA28␥ but not with PA28␣ and ␤. 30 However, even if core protein initially attaches to PA28␥, we cannot exclude that ␥ subunit subsequently activates ␣ subunit in PA28-20S proteasome preparation, thereby increasing chymotrypsin-like proteasome activity. This core-induced proteasome activation was further enhanced by addition of exogenous recombinant PA28␣.
In HCV-expressing cells, core protein is located between the outer mitochondrial membrane and the ER. 6 To mimic this cellular interaction in a cell-free system, we measured whether proteasome activation by core protein was further modulated by mitochondria and/or microsomes. Each subcellular fraction, either alone or in combination, potentiated proteasome activation by core protein. The activating effect of mitochondria was not dependent on their structural integrity because both frozen and freshly isolated mitochondrial preparations equally enhanced core protein-mediated 20S proteasome activation. Therefore, proteasomal activation was likely the result of interactions between 20S-PA28 complex and specific mitochondrial protein(s), possibly, in/on the outer membrane. This is consistent with findings of others that core protein has a strong tendency to associate with various proteins, such as STAT1 and Jaks, affecting their functions. 31, 32 Interestingly, the cross talk between core-activated proteasome and mitochondria or/and microsomes was blunted in the presence of mitochondria or microsomes from ethanol-fed mice, indicating that ethanol-induced dysregulation of protein expression in these organelles may be attributed to their adduction by oxidants.
The nature of the putative proteasome-interacting protein(s) in mitochondria and ER is not clear. Heat shock proteins (HSP) are potential candidates for providing communication between mitochondria, microsomes, and the proteasome because the role of HSP in interactions between the microsomal enzyme CYP2E1 and the proteasome has been established. 33 Mitochondria may also affect the activity of 20S-PA28 complex via interactions between mitochondrial HSP70 and PA28 because mitochondria express HSP70 34 and the association between HSP70 and PA28 during substrate refolding has been reported. 35 The physiologic and pathogenic relevance of proteasome activation by core protein is in an enhanced ability of proteasome to cleave the substrate proteins. Because some HCV proteins (such as NS5B as well as nuclear core protein) are targeted by proteasome, 36 their rapid degradation may be favorable for HCV elimination. However, these proteins, in turn, form stable complexes with other important signaling proteins, thereby facilitating the removal of HCV-signaling factor complexes by proteasome. For example, in HCV protein-expressing cells, the depletion of STAT1, a signal transduction factor for interferons, may be potentially attributed to enhanced proteasome function as demonstrated by suppression of STAT1 disappearance in the presence of the proteasome inhibitor, MG132. 37 Similarly, activation of proteasome by viral proteins leads to degradation of protective factors, as observed in other viral infections. 38 However, even if core protein enhances proteasome activity, this may not result in tremendously increased generation of peptides for MHC class I-restricted antigen presentation because the most antigen-processing enzymes (including proteasome) are activated by interferon, and, to be effective, peptide processing requires unaltered interferon signaling, whereas STAT1 is degraded by the proteasome. If core-positive/CYP2E1-expressing liver cells are exposed to ethanol, ethanol metabolism suppresses proteasome activity. This may prevent the degradation of the "protective" proteins, such as STAT1, but will ultimately block STAT1 phosphorylation. 27 The processing of viral peptides for antigen presentation by liver cells will be further suppressed because, in this case, ethanol metabolism not only suppresses proteasome-dependent cleavage of antigenic peptides but also prevents interferon signaling by altering STAT1 phosphorylation. The outcomes of core-induced proteasome activation and the suppressing effects of ethanol exposure for innate and adaptive immunity, as well as the identification of proteins involved in HCV core-proteasome-mitochondrion-ER interactions, will be the subject of future investigations. A proposed mechanism of core-proteasome interactions in liver cells is depicted in Figure 6 .
In summary, HCV core protein enhanced 20S proteasome activity directly, by facilitating interactions among 20S proteasome, PA28, and mitochondria/microsomes and, indirectly, via generation of low levels of oxidants. Elevated oxidant generation by ethanol metabolism and disruption of core-20S-PA28-mitochondrial interactions ultimately results in reduced liver proteasome activity that may influence the propagation of HCV clinical course in alcoholic patients. Figure 6 . Proposed mechanism of regulation of proteasome function by core protein in liver cells. Core protein stimulates proteasome, directly facilitating PA28-20S interaction. These effects are potentiated by mitochondrial and microsomal protein(s), which further enhance proteasome activation by core protein. In addition, HCV core protein induces a low level of oxidative stress and also increases proteasome activity. Treatment of core-expressing CYP2E1 ϩ cells by ethanol disrupts interactions between 20S proteasome-PA28 complex and mitochondria and creates a high level of oxidative stress, which suppresses proteasome activity.
